Assessment of Azeliragon QTc Liability Through Integrated, Model‐Based Concentration QTc Analysis.
Autor: | Burstein, Aaron H.1 (AUTHOR) aburstein@vtvtherapeutics.com, Brantley, Scott J.2 (AUTHOR), Dunn, Imogene1 (AUTHOR), Altstiel, Larry D.3 (AUTHOR), Schmith, Virginia1 (AUTHOR) |
---|---|
Zdroj: | Clinical Pharmacology in Drug Development. May2019, Vol. 8 Issue 4, p426-435. 10p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |